Text Size
14 studies found for:    Open Studies | "Poxviridae Infections"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Safety Surveillance Study of ACAM2000® Vaccinia Vaccine
Condition: Smallpox
Intervention: Biological: ACAM2000® smallpox vaccine
2 Recruiting Safety and Immunogenicity Study of AIDS Vaccine (Combined Use of DNA Vaccine and Recombinant Vaccinia Virus Tiantan)
Condition: AIDS
Interventions: Biological: DNA vaccine;   Biological: DNA vaccine prime with the addition of electroporation;   Biological: rTV boost at week 16;   Biological: rTV boost at week 24;   Biological: rTV boost at week 32
3 Recruiting Safety of and Immune Response to a DNA HIV Vaccine Boosted With a Modified Vaccinia HIV Vaccine and Protein HIV Vaccine in Healthy Adults
Conditions: HIV Seronegativity;   HIV Preventive Vaccine
Interventions: Biological: MVA-C + gp140/MF59;   Biological: DNA-C2 + MVA-C;   Biological: DNA-C2 + MVA-C + gp140/MF59
4 Recruiting A Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects
Condition: Smallpox
Interventions: Biological: IMVAMUNE;   Other: Placebo
5 Recruiting A Phase II Trial to Compare a Liquid-frozen and a Freeze-dried Formulation of IMVAMUNE (MVA-BN®) Smallpox Vaccine in Vaccinia-naïve Healthy Subjects
Condition: Smallpox
Interventions: Biological: LF formulation of IMVAMUNE®;   Biological: FD formulation of IMVAMUNE®
6 Recruiting Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma
Conditions: Colorectal Carcinoma;   CRC
Interventions: Biological: JX-594;   Drug: Irinotecan
7 Recruiting Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma
Condition: Lung Cancer
Intervention: Biological: GL-ONC1
8 Unknown † Safety and Efficacy of CJ-50300 in Healthy Volunteers
Condition: Smallpox
Intervention: Biological: smallpox vaccine CJ-50300
9 Recruiting A Study of GL-ONC1, an Oncolytic Vaccinia Virus, in Patients With Advanced Peritoneal Carcinomatosis
Condition: Peritoneal Carcinomatosis
Intervention: Biological: GL-ONC1
10 Not yet recruiting Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
Condition: Smallpox
Intervention: Biological: IMVAMUNE®
11 Recruiting Immune Responses to Smallpox Vaccination
Condition: Smallpox Vaccine
Intervention:
12 Recruiting Safety Surveillance Cohort Study of Vaccinia Vaccine (ACAM2000®)
Condition: Smallpox
Intervention:
13 Recruiting Safety Study of Attenuated Vaccinia Virus (GL-ONC1)With Combination Therapy in Head & Neck Cancer
Condition: Cancer of Head and Neck
Intervention: Biological: GL-ONC1
14 Unknown † Efficacy and Tolerance of Potassium Hydroxide (10% and 15%) in Molluscum Contagiosum
Condition: Molluscum Contagiosum
Interventions: Drug: Hydroxide Potassium;   Drug: Placebo
To Top

† Indicates status has not been verified in more than two years